Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. [electronic resource]
Producer: 20120727Description: 1914-25 p. digitalISSN:- 1460-2156
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- adverse effects
- 3,4-Dihydroxyphenylacetic Acid -- metabolism
- Animals
- Brain -- drug effects
- Chromatography, High Pressure Liquid
- Disease Models, Animal
- Enzyme-Linked Immunosorbent Assay
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- metabolism
- Homovanillic Acid -- metabolism
- Injections, Subcutaneous
- Male
- Mice
- Mice, Inbred C57BL
- Motor Activity -- drug effects
- Neurons -- drug effects
- Neuroprotective Agents -- therapeutic use
- Parkinson Disease -- blood
- Polyethylene Glycols -- metabolism
- Rats
- Rats, Wistar
- Recombinant Proteins -- metabolism
- Rotarod Performance Test
- Time Factors
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.